Orthovis Preoperative Plan
by Custom Orthopaedic Solutions
510(k) K133367
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK133367 | Date20 Dec 2013 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LLZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Orthovis Preoperative Plan is a preoperative plan document generated through the Orthovis software platform. It is designed to facilitate accurate preoperative planning and the intraoperative placement of the glenoid component during total shoulder replacement procedures.
This device is authorized under FDA 510(k) clearance K133367. It provides surgeons with an interactive, patient-specific view to assist in surgical planning.
Other devices from Custom Orthopaedic Solutions, Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the primary purpose of the Orthovis Preoperative Plan?
This device is designed to facilitate accurate preoperative planning for total shoulder replacement procedures. It provides surgeons with an interactive, patient-specific view to assist in the precise intraoperative placement of the glenoid component.
How is the Orthovis Preoperative Plan generated?
The plan is generated through the Orthovis software platform. It utilizes patient-specific data to create an interactive view that surgeons use to prepare for shoulder replacement surgery.
What is the regulatory status of this device?
The Orthovis Preoperative Plan is authorized under FDA 510(k) clearance K133367. It was determined to be substantially equivalent to existing devices through a traditional clearance process.